|
- 2018
Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL)DOI: 10.1007/s41669-017-0048-x Abstract: The online version of this article (doi:10.1007/s41669-017-0048-x) contains supplementary material, which is available to authorized users
|